AIAI Share Price Performance
Recent AIAI News & Updates
No updates
NetraMark Holdings Inc. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.049
- Gross Margin
- 100.00%
- Net Profit Margin
- -658.73%
- Debt/Equity Ratio
- 0%
NetraMark Holdings Inc. Competitors
About AIAI
- Founded
- 2016
- Employees
- n/a
- CEO
- WebsiteView website
NetraMark Holdings Inc. develops artificial intelligence and machine learning solutions for the pharmaceutical industry in Canada. The company’s product suite comprises Netra Shatter; Netra Health Atlas; and NetraAi that is designed to help interact and explore with different perspective of the data for clinical trials. It provides NetraPlacebo module that analyzes past trial data to determine what drives placebo responses to guide inclusion/exclusion criteria; and Netra GPT module that offers insights from past clinical trials about the patient’s population by utilizing established medical literature. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. The company was founded in 2016 and is headquartered in Toronto, Canada.
Canadian Market Performance
- 7 Days: 0.4%
- 3 Months: 10.1%
- 1 Year: 17.4%
- Year to Date: 10.2%
The market has been flat over the last week. As for the longer term, the market has risen 17% in the past 12 months. As for the next few years, earnings are expected to grow by 12% per annum. Market details ›
Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
Continue reading